CLDN1 and breast cancer: Examination of mesenchymal markers revealed that IFN-β not only inhibited the OSM-mediated expression of CD44, but also prevented repression of Claudin-1 and E-cadherin (epithelial markers associated with less aggressive breast cancers) (Fig. 1d).